Category Archives: health and fitness

Health and Fitness, is important to living a healthy life. Learn the newest research from our Press Releases today.

Memorial Neuroscience Institute Performs Livestreamed Brain Aneurysm Procedure


“Memorial’s Neuroscience Institute is one of the first pilot sites selected by the Society of Vascular and Interventional Neurology (SVIN) for a global tele-observership program using virtual proctoring software such as Proximie,” said Dr. Mehta. “It’s an innovative technology that has the potential to train physicians around the world, especially in developing countries, on the latest stroke treatments and neurointerventional techniques.”

Drs. Mehta and Delgado utilized a minimally-invasive, endovascular treatment on Stephane Desjardins to treat the brain aneurysm, one that had a high probability of being fatal if it had ruptured and bled in the brain. The catheter-based image navigation procedure enabled the placement of the WEB device to secure the aneurysm. The procedure was a success due to the real-time virtual proctoring made possible with the Proximie system.

Approximately 30,000 people in the United States suffer a brain aneurysm rupture each
year, according to the Brain Aneurysm Foundation.

“I had worsening headaches, was dizzy, nauseous, and had no energy,” said Desjardins, whose aneurysm was discovered during a CT scan when he presented to the Memorial Regional Hospital emergency room. “Dr. Mehta got me in right away and I’ve haven’t had any issues since the procedure.”

The 53-year-old Desjardins was discharged from the hospital a day after the cutting-edge surgery without any neurological impairments and returned to a meaningful quality of life with his family.

Memorial Neuroscience Institute offers advanced diagnoses, comprehensive treatment, compassionate care, and rehabilitation for complex neurological conditions. Few centers can match the depth of its neurological expertise or the wide range of available services.

Part of the Memorial Healthcare System and recognized for its quality and safety, the institute treats conditions of the brain that include Alzheimer’s and Parkinson’s disease, multiple sclerosis, tumors, epilepsy, stroke, and subarachnoid hemorrhages, as well as issues of the neck, back, and spine.

To learn more about the complete continuum of neurological care Memorial provides, visit http://www.mhs.net/neuroscience.

Media Contact

Yanet Obarrio Sanchez, Memorial Healthcare System, 954-265-1136, [email protected]www.mhs.net 

SOURCE Memorial Healthcare System

Call Box Releases Call Tags, Revolutionizing Call Management and Boosting Productivity


Call Box is thrilled to announce the release of an exciting new feature, Call Tags. This feature is set to transform the way healthcare practices and professionals manage their calls, offering immediate benefits and improved efficiency.

DALLAS, Nov. 9, 2023 /PRNewswire-PRWeb/ — Call Box, a leader in innovative call management solutions, is thrilled to announce the release of an exciting new feature, Call Tags. This feature is set to transform the way healthcare practices and professionals manage their calls, offering immediate benefits and improved efficiency.

Call Tags, the latest enhancement from Call Box, allow easily identifiable tags to be placed on each call recording based on specific topics or phrases mentioned by the patient. With Call Tags, you can now easily identify and prioritize calls, making it simpler to find and access critical information from your conversations.

Furthermore, this enhanced feature allows users to search for calls, via Call Box’s Search for a Call feature, by tag for a quicker and simpler user experience. This enables healthcare practices to quickly sort through patient calls when building outbound campaigns, following up on urgent requests, and finding any missed appointment opportunities with high value.

“Call Tags represent a significant leap forward in call management. With this innovative feature, we empower our clients to harness the power of organization and efficiency,” states Executive Vice President of Product and Marketing, Jackie Bowers. “Call Tags streamline the process of finding and categorizing calls, ultimately saving valuable time and ensuring that crucial conversations are never missed. We believe that Call Tags will revolutionize the way professionals across the healthcare industry manage their calls, providing immediate, tangible benefits.”

The initial category of Call Tags being introduced is Procedure Tags. These tags are automatically generated from transcriptions and designed to identify medical procedures mentioned by the patient. With Procedure Tags, professionals can effortlessly search and categorize calls related to specific medical procedures, saving time and increasing productivity. Call Tags will be available for the following industries: Dental, Veterinary, Orthopedics, and Plastics. We will continue to expand our list of supported industries in the future.

Call Box prides itself on being the healthcare industry’s leader when it comes to call tracking and phone handling solutions. Being at the forefront of technology, Call Box continues to break barriers and find solutions to generate optimal phone performance for its clients.

About Call Box

As the leading provider of comprehensive phone solutions, Call Box believes the phone should be an asset to your organization, not an overwhelming liability to manage. Being top-notch on the phone shouldn’t be complicated or time-consuming. That’s where Call Box comes in. Call Box leverages human reviewers and artificial intelligence to track, review, and analyze 100% of the calls generated by thousands of healthcare practices. This allows managers to gain in-depth, actionable insight into the outcome of their calls to connect with more patients, improve caller experience, and convert more appointments opportunities.

For more information regarding Call Box, please contact us at [email protected].

Media Contact

Alyssa Whitmore, Call Box, 1 888-815-6426, [email protected], https://www.callbox.com/

SOURCE Call Box

Formulating for Gut Health with Bio Hemp Fiber Crisps, Upcoming Webinar Hosted by Xtalks


The new Bio Hemp Fiber Crisp is not only a great way to add fiber, but also bioactives that support gut health, and a pleasing sensory experience with textured crisps that can be utilized in a variety of applications. This webinar will be great for those who are looking for new ways to bring fiber to a product line or are interested in how this upcycled hemp product can work with their portfolio. Additionally, one of the latest fiber ingredients to come to market has the potential to be uniquely appealing to gut health consumers.

Register for this webinar to learn about fiber trends and formulating products for gut health with PGP’s Bio Hemp Fiber Crisp.

Join Kevin Andrews, Sr. Business Development Manager, PGP International; Alina Slotnik, VP of Bioactives, Brightseed; and Miranda Ackerman, Product Marketing Manager, PGP International, for the live webinar on Wednesday, November 15, 2023, at 1pm EST (10am PST).

For more information, or to register for this event, visit Formulating for Gut Health with Bio Hemp Fiber Crisps.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com.
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/.

Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

A Collaborative Partnership for Innovation and Quality Patient Care


Brandon Stroh, M.D., Founder and CEO of Inspire Radiology, stated, “By partnering with INFINITT, we ensure unparalleled flexibility and adaptability for our practice and healthcare partners. Their highly customizable PACS solution enhances operational workflow and enables seamless access to crucial patient information across our networks. This partnership underscores Inspire Radiology’s commitment to delivering high-quality patient care through innovative technology solutions.”

Teleradiology’s numerous advantages include improved access to specialized expertise. Remote interpretation of medical images by radiologists allows them to share findings with physicians and other healthcare providers in different locations. This means patients in rural or remote areas can receive specialized diagnostic services without extensive travel. Additionally, teleradiology facilitates collaboration and learning among radiologists while offering a platform for professional second opinions on digitized diagnostic scans, ultimately providing patients with the best care possible.

INFINITT’s in-house researched and developed PACS solutions aim to enhance collaboration with features like real-time image capture, transmission, and communication capabilities. Radiologists can navigate key image sections swiftly to direct attention to where it matters most.

“INFINITT’s interoperable-first approach streamlines workflow and accessibility of images and data. Our cloud-based solutions enable outsourcing imaging IT infrastructure so that patient care remains the prime focus,” said Dave Smarro, CEO of INFINITT.

As Inspire Radiology anticipates significant growth in the coming years, achieving both improved user experience and enhanced patient care is a major victory for the organization.

Both companies share a mission of providing customized solutions, seamless integration, timely and accurate reporting, and fostering a collaborative partnership. Smarro adds, “We are thrilled to be part of revolutionizing radiology and will continue to do so.”

For more information visit: www.infinittna.com www.inspireradiology.com

Media Contact

Shannon Spak, INFINITT North America, 1 877-387-6960, [email protected], https://www.infinittna.com/

LinkedIn

SOURCE INFINITT North America

Veradermics Doses First Patient in a First-in-Human Clinical Trial for VDPHL for the Treatment of Pattern Hair Loss (Androgenetic Alopecia)


VDPHL is a once-daily non-hormonal oral therapeutic being developed as a treatment for pattern hair loss

NEW HAVEN, Conn., Nov. 7, 2023 /PRNewswire-PRWeb/ — Veradermics Inc., a clinical-stage medical dermatology company with a pipeline of first-in-class product candidates targeting highly prevalent immunologic and dermatologic conditions, today announced it has commenced dosing in a First-in-Human clinical trial of VDPHL, an investigational, proprietary, non-hormonal oral treatment being developed for pattern hair loss.

Pattern hair loss, also known as androgenetic alopecia, is the most common form of hair loss in the world, impacting 50 million men and 30 million women in the U.S. alone. Existing treatments include topical minoxidil, which faces high discontinuation rates, and oral finasteride, which is only FDA-approved for men and can be associated with unwanted sexual side effects. Veradermics’ VDPHL, a non-hormonal oral therapeutic, has the potential to become a preferred treatment approach for both men and women suffering from pattern hair loss.

“Veradermics is extremely excited to take a step towards addressing the pervasive therapeutic challenge associated with treating pattern hair loss,” said Reid Waldman, MD, CEO of Veradermics. “VDPHL is our second proprietary product candidate advanced into clinical trials in 2023, highlighting the company’s steadfast commitment in and progress towards developing treatments for common skin conditions.”

In 2023, Veradermics also announced the initiation of a Phase 2 trial evaluating VDMN, an immunostimulatory dissolvable microarray patch containing Candida Antigen Extract, for the treatment of common warts. Veradermics’ five-asset pipeline also includes product candidates targeting conditions including alopecia areata, atopic dermatitis, and molluscum contagiosum. The company plans to advance multiple additional product candidates into the clinic in 2024.

“The pattern hair loss treatment landscape urgently needs evidence-based solutions,” added Tim Durso, MD, President of Veradermics. “An oral, non-hormonal treatment like VDPHL has the potential to dramatically change the way hair loss is treated. We are thrilled to announce the dosing of our first patient and are optimistic about the potential impact of VDPHL in this therapeutic category.”

About Veradermics:
Veradermics is a clinical-stage biopharmaceutical company led by experts in dermatology, drug development, and pharmaceutical commercialization that is backed by leading investors in biotech. The company’s 5-asset portfolio includes a balance of late-stage and early-stage product candidates targeting highly prevalent immunologic and dermatologic diseases. Founded by dermatologists, Veradermics leverages its front-line clinical experience to identify and advance novel drugs that address specific patient needs and solve pervasive treatment challenges in dermatology practice. Target indications include common warts, alopecia areata, molluscum contagiosum, androgenetic alopecia (pattern hair loss), and atopic dermatitis. For more information, visit http://www.veradermics.com.

Forward-Looking Statements:
This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words, including “believe”, “may” and “will” and similar expressions, are intended to identify forward-looking statements. These forward-looking statements involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of Veradermic’s management about VDMN as treatment for patients with skin disease. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by our forward-looking statements. The forward-looking statements are made as of this date and Veradermics does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. 

Media Contact

Reid Waldman, Veradermics, 913-787-6489, [email protected], https://www.veradermics.com/

SOURCE Veradermics

Bellagena Med Spa Continues Partnership With Exclusive Haute Beauty Network


As much as Bellegena is a place to relax, it’s also the place to go when your skin needs resuscitation. Many factors, such as diet and exercise, are responsible for your skin’s radiance. By emphasizing this important tenant, the experts at Bellagena have masterfully created skin treatments to fit every lifestyle. They have made it their mission to give skin a revitalizing lift after years of neglect. Sporting signature facials, microdermabrasion, chemical peels, and the very best expertise in dermaplaning, every client can expect to emerge anew.

Expert Massage Therapies

The spa’s holistic approach also greets clients with a treasure trove of the best massages delivered by their expert massage therapists. Furthering healing is the goal with any of their custom massages that boost the immune system, alleviate pain and increase circulation.

Beauty Treatments That Relax Your Mind

Like massage affords relaxation to the body, let their beauty treatments relax your mind. An array of their best skin care treatments, massage therapy, microdermabrasion and infrared sauna are at your disposal. Combine any of these with aromatic body wraps and scrubs and you will have put your mind at ease while putting your best foot forward.

Prepare for absolute radiance when you place your skin in the hands of the experts at Bellagena Skin Care Studio & Day Spa.

Learn more about Bellagena Med Spa by visiting: https://hauteliving.com/hautebeauty/member/bellagena-med-spa/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Media Contact

Grace Sarkisian, Haute Beauty by Haute Living, (813)-260-0767, [email protected], https://hauteliving.com/hautebeauty/

SOURCE Haute Beauty by Haute Living

Ideal Option Hosts “Testing for Turkeys” Community Resource Event in Baltimore


All members of the community are welcome to engage in free onsite healthcare services at Bel Park Towers on Friday, November 17, 10 a.m.2 p.m.

BALTIMORE, Nov. 6, 2023 /PRNewswire-PRWeb/ — Ideal Option, a national leader in outpatient medication-assisted treatment for opioids, methamphetamine, alcohol and polysubstance, is partnering with Johns Hopkins Medicine, Park West Health System, Maryland Wellness and other organizations to host Testing for Turkeys, a community resource event for residents of Baltimore. Attendees that participate in free onsite healthcare services are eligible to receive a free turkey and side dishes (while supplies last).

The event will provide access to underutilized healthcare services such as HIV testing, mental health, primary care and addiction treatment. According to a nationwide tracker of drug overdose deaths released by the San Francisco Chronicle, Baltimore has the highest number of fatalities in the country. In addition, as stated in a recent case study by the Milbank Memorial Fund, “Several parts of the city are classified as primary care health professional shortage areas, and many policy initiatives have been implemented to make primary care more accessible, but barriers persist.”

Testing for Turkeys will take place on Friday, November 17, 10 a.m.2 p.m. at Bel Park Towers at 3800 W Belvedere Ave. Attendees will have the chance to meet with various community organizations, engage in free onsite services, and pick up educational materials.

Onsite services available at the event:

  • Hep C and HIV rapid testing
  • Blood pressure checks and MAT consultations
  • Referrals and appointment scheduling for healthcare services such as mental health, addiction treatment, adult medicine and dentistry.

For questions about this event, email Olivia Roe, marketing director for Ideal Option, at [email protected].

About Ideal Option 

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 70,000 patients through a network of 90+ office-based medication-assisted treatment (MAT) clinics across 9 states. With a mission to serve under-served communities, Ideal Option accepts all forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available. 

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism. 

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support. 

Media Contact

Olivia Roe, Ideal Option, 1 9199466644, [email protected], www.idealoption.com

TwitterFacebookLinkedIn

SOURCE Ideal Option



United Nations’ Family Planning 2030 Office Partners with RS21 to Develop FP2030 Data Hub and Global Data Dashboard


The effort will provide accessible, comprehensive data for informed decision-making.

ALBUQUERQUE, N.M., Nov. 6, 2023 /PRNewswire-PRWeb/ — Within the realm of reproductive health, FP2030 is leading an impactful initiative that emphasizes the critical role of family planning in achieving a number global development priorities. Known as FP2030, the global partnership advances person-centered, rights-based family planning for all people everywhere. To develop and redesign their data hub and create a global interactive data dashboard, FP2030 has partnered with RS21, a data science company and Inc. 5000 fastest-growing company three years in a row.

“At the core of the FP2030 partnership is the commitments made by governments, donors and other organizations investing in expanding access to family planning. Having current, reliable data is crucial as our partners determine where to invest their resources,” said Jason Bremner, FP2030 Senior Director for Data and Measurement. “This new global data dashboard that we are developing with RS21 will increase data availability through improved access, visualization, and comparison of family planning, finance, and policy data aggregated as part of our FP2030 Measurement Framework.”

The FP2030 data hub and global data dashboard will integrate, centralize and visualize region-specific data and provide important cross-national information about family planning services worldwide to support people’s access to quality, voluntary family planning resources.

“We are honored to partner with FP2030 to deliver a dynamic, interactive dashboard that not only empowers individuals to make informed choices but also advances the profound belief that every woman and girl around the world deserves access to modern contraception, comprehensive reproductive health services, and family planning resources,” said Charles Rath, President and CEO of RS21. “This is the type of initiative that RS21 was founded to support—using data for good and helping leaders drive programs that improve people’s lives.”

RS21 brings a deep knowledge of cross-national family planning and contraception data, design expertise and an extensive data analytics bench to FP2030. Katie Webster, PhD, is RS21’s Director of Data Analytics and lead analyst for the dashboard. She explained, “Several of our staff are experts in comparative politics and healthcare, with deep familiarity in the leading datasets and initiatives in this space. We could not be more thrilled about this incredible opportunity to leverage our substantive and technical expertise to deliver global value and advance FP2030’s mission of reproductive empowerment and rights-based family planning.”

The team building the FP2030 data hub emphasizes the importance of diversity and inclusion, particularly in a collaborative team structure based on the collective strengths of multiple subject matter experts spanning regions and cultures. Through this effort, FP2030’s global partnership of governments, civil society, multilateral organizations, donors, private sector partners and researchers will be able to contribute to a more integrated and collaborative approach in supporting the network’s goals. The work will begin in 2023.

About FP2030

FP2030 is a global partnership dedicated to promoting and expanding access to family planning services. Comprising governments, civil society organizations, private sector partners, and development agencies, FP2030 works collaboratively to advance family planning as a fundamental human right and an essential component of sustainable development.

About RS21

RS21 is a rapidly growing data science company that uses artificial intelligence, design, data engineering, and modern software development methods to empower organizations to make data-driven decisions that positively impact the world. Our innovative solutions are insightful, intuitive, inspiring, and intellectually honest. With teams in Albuquerque, NM and Washington, DC and distributed throughout the United States, RS21 is an Inc. 5000 fastest-growing company two years in a row and a Fast Company Best Workplace for Innovators.

We help clients achieve programmatic goals, improve efficiencies, reduce costs, and maximize productivity using MOTHR, our human-centered, artificial intelligence engine that allows users to seamlessly integrate data and reveal insights at hyper speed. We navigate complex data issues in the fields of healthcare, defense, safety, urban planning, energy, cyber, land use, climate, disaster preparedness, disaster recovery, space, and social equity. For more information, visit http://www.rs21.io.

Media Contact

Natalie Sommer, RS21, 1 505-615-1356, [email protected], https://rs21.io

Em Chadband, FP2030, [email protected]

SOURCE RS21

The Conference Forum Launches Network of Websites to Support Pharma R&D


The new websites will serve the following markets:

These markets will now have their own dedicated websites with completely redesigned conference portions to easily navigate the agenda, tech presentations, speaking faculty, partnering and networking; and comprehensive and in-depth coverage on the information impacting research and development through articles, webcasts and podcasts.

The brands include:

The parent website will remain theconferenceforum.org to provide easy access to the entire portfolio.

“We are delighted to launch the new websites when there is more need than ever before to connect in the exciting, complex medicine development ecosystem,” said Meredith Sands, Executive Director, Business Development, The Conference Forum.

About the Conference Forum:
The Conference Forum is a life science industry research and marketing firm. The company brings the full spectrum of executives together to share ideas and information on how to advance efficient medicine development and delivery, patient diversity and access. They produce trusted conferences, webinars, podcasts, digital editorial and marketing.

Media Contact
Bre Bugbee, The Conference Forum, 1-646-350-2580, [email protected], https://theconferenceforum.org/ 

SOURCE The Conference Forum